News
2d
Flow Space on MSNA New Option for Hot Flashes: What the Research Says About ElinzanetantHot flashes happened less often and were less severe in women who took elinzanetant compared to those who took a placebo. The ...
Objective: To update and expand The North American Menopause Society’s evidence-based position on nonhormonal management of menopause-associated vasomotor symptoms (VMS), previously a portion of ...
Vasomotor symptoms, such as hot flashes, are widely recognized, but there are dozens of other menopausal symptoms that a woman can experience. Not All Menopausal Symptoms Are the Same, in Terms of ...
Research suggests women with high breast cancer risk and menopausal symptoms could benefit from Duavee, which reduced breast ...
Elinzanetant proved effective for managing disruptive vasomotor symptoms in women on endocrine therapy, supporting a Bayer ...
Discover 12 key menopause symptoms that disrupt daily life. Learn to recognize hot flashes, mood changes, sleep issues and ...
Those with greater menopausal symptoms had higher scores ... “It is believed that the vasomotor symptoms are correlated with development of white matter hyperintensities in the brain, akin ...
For women with moderate-to-severe vasomotor symptoms associated with endocrine therapy for hormone receptor (HR)-positive ...
Simon J, Pinkerton J, Maki P, et al. Efficacy of elinzanetant for the treatment of vasomotor symptoms associated with menopause: pooled data from two phase 3 studies. Presented at: AMCP 2025 ...
Despite a renaissance in menopause awareness, the over-medicalisation of women’s midlife health threatens to eclipse foundational interventions like physical activity. Menopause is a pivotal milestone ...
3d
MedPage Today on MSNNon-Hormonal Drug Reduced Hot Flashes From Endocrine Therapy for Breast CancerCHICAGO -- The neurokinin-targeted agent elinzanetant significantly reduced the frequency of hot flashes among women ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results